EVALUATION OF SERUM KL-6 LEVELS IN PATIENTS WITH PULMONARY TUBERCULOSIS

被引：48

作者：

INOUE, Y

NISHIMURA, K

SHIODE, M

AKUTSU, H

HAMADA, H

FUJIOKA, S

FUJINO, S

YOKOYAMA, A

KOHNO, N

HIWADA, K

机构：

[1] EHIME UNIV, SCH MED, DEPT INTERNAL MED 2, SHIGENOBU, EHIME 79102, JAPAN

[2] EHIME NATL HOSP, SHIGENOBU, EHIME, JAPAN

来源：

TUBERCLE AND LUNG DISEASE | 1995年 / 76卷 / 03期

关键词：

D O I：

10.1016/S0962-8479(05)80010-3

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Setting: KL-6, a human MUC-1 mucin preferentially expressed on type II pneunocytes, is a sensitive serum marker for evaluating alveolar damage of interstitial pneumonia and pulmonary fibrosis. Some patients with pulmonary tuberculosis develop severe respiratory dysfunction caused by extensive pulmonary fibrosis, compensatory emphysema and fibrous pleural thickening. Objective: To evaluate the clinico-pathological significance of KL-6 in pulmonary tuberculosis. Design: Serum KL-6 levels were measured in sera from 57 patients with active pulmonary tuberculosis and 38 healthy controls by a sandwich-type enzyme-linked immunosorbent assay. Immunohistochemistry was performed by an avidin-biotin-peroxidase complex method. Results: KL-6 levels were significantly higher in the patients than in the healthy controls (518 +/- 693 [SD] vs 227 +/- 91 U/ml, P < 0.001) and increased significantly according to the extent of pulmonary lesions evaluated by chest X-ray (P < 0.001). There was a significant negative correlation between serum KL-6 levels and % vital capacity (VC) (r = 0.642, P < 0.05). KL-6 was strongly expressed on proliferated type II pneumocytes and cuboidal epithelial cells adjacent to thickened intralobular septa and pleura. Conclusions: In pulmonary tuberculosis, serum KL-6 originates from proliferated type II pneumocytes and cuboidal epithelial cells, and is a useful marker presenting the degree and extent of pulmonary fibroproductive lesions.

引用

页码：230 / 233

页数：4

共 15 条

[1]

Kohno, Akiyama, Kyoizumi, Et al., Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma, Jpn J Clin Oncol, 18, pp. 203-216, (1988)

[2]

Kohno, Kyoizumi, Tanabe, Et al., Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay, Cancer Res, 49, pp. 3412-3419, (1989)

[3]

Hamada, Kohno, Hiwada, A new serum tumor marker, CAM 123–6, highly specific to pulmonary adenocarcinoma, Jpn J Cancer Res, 85, pp. 211-219, (1994)

[4]

Stahel, Gilks, Lehmann, Schenker, Third international workshop on lung tumor and differentiation antigens overview of the results of the central data analysis, International Journal of Cancer, pp. 6-26, (1994)

[5]

Kohno, Inoue, Hamada, Et al., Difference in serodiagnostic values among KL-6-associated mucins classified as Cluster 9, International Journal of Cancer, pp. 81-83, (1994)

[6]

Kohno, Kyoizumi, Awaya, Fukuhara, Yamakido, Akiyama, New serum indicator of interstitial pneumonitis activity: sialylated carbohydrate antigen KL-6, Chest, 96, pp. 68-73, (1989)

[7]

Kohno, Awaya, Oyama, Et al., KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease, Am Rev Respir Dis, 148, pp. 637-642, (1993)

[8]

Hamada, Kohno, Akiyama, Hiwada, Monitoring of serum KL-6 antigen in a patient with radiation pneumonia, Chest, 101, pp. 858-860, (1992)

[9]

Kohno, Hamada, Fujioka, Hiwada, Yamakido, Akiyama, Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer, Chest, 102, pp. 117-122, (1992)

[10]

Newell, Chamberlain, Rigler, Descriptive classification of pulmonary shadows: a revelation of unreliability in the roentgenographic diagnosis of tuberculosis, Am Rev Tuberc, 69, pp. 566-584, (1954)

← 1 2 →